Use of the EsoGuard® Molecular Biomarker Test in Non-Endoscopic Detection of Barrett’s Esophagus among High-Risk Individuals in a Screening Population
Nicholas J. Shaheen, Mohamed O. Othman, Jawar Taunk, Kenneth J. Chang, Sathya Jaganmohan, Patrick S. Yachimski, John C. Fang, Joseph S. Spataro, Suman Verma, Victoria T. Lee, Brian J. deGuzman, Lishan Aklog
doi: https://doi.org/10.1101/2024.06.24.24309401
Nicholas J. Shaheen
1Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
MD, MPHMohamed O. Othman
2Gastroenterology and Hepatology Section, Baylor College of Medicine, Houston, TX, USA
MDJawar Taunk
3Advanced Gastroenterology Associates, Palm Harbor, FL, USA
MDKenneth J. Chang
4University of California, Irvine Medical Center, Orange, CA, USA
MDSathya Jaganmohan
5Louisiana Research Center, Shreveport, LA, USA
MDPatrick S. Yachimski
6Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, TN, USA
MDJohn C. Fang
7Division of Gastroenterology, Hepatology and Nutrition, University of Utah, Salt Lake City, Utah, USA
MDJoseph S. Spataro
8Central Virginia VA Health Care System, Richmond, VA, USA
MDSuman Verma
9Lucid Diagnostics Inc., New York, NY, USA
MD, PhDVictoria T. Lee
9Lucid Diagnostics Inc., New York, NY, USA
MDBrian J. deGuzman
9Lucid Diagnostics Inc., New York, NY, USA
MDLishan Aklog
9Lucid Diagnostics Inc., New York, NY, USA
MD
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted June 26, 2024.
Use of the EsoGuard® Molecular Biomarker Test in Non-Endoscopic Detection of Barrett’s Esophagus among High-Risk Individuals in a Screening Population
Nicholas J. Shaheen, Mohamed O. Othman, Jawar Taunk, Kenneth J. Chang, Sathya Jaganmohan, Patrick S. Yachimski, John C. Fang, Joseph S. Spataro, Suman Verma, Victoria T. Lee, Brian J. deGuzman, Lishan Aklog
medRxiv 2024.06.24.24309401; doi: https://doi.org/10.1101/2024.06.24.24309401
Use of the EsoGuard® Molecular Biomarker Test in Non-Endoscopic Detection of Barrett’s Esophagus among High-Risk Individuals in a Screening Population
Nicholas J. Shaheen, Mohamed O. Othman, Jawar Taunk, Kenneth J. Chang, Sathya Jaganmohan, Patrick S. Yachimski, John C. Fang, Joseph S. Spataro, Suman Verma, Victoria T. Lee, Brian J. deGuzman, Lishan Aklog
medRxiv 2024.06.24.24309401; doi: https://doi.org/10.1101/2024.06.24.24309401
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)